December 2-4, 2020 | 10:00AM EST | 3:00PM UTC*
*Program is subject to change
The aim of this symposium is to mobilize the rigor, creativity and forward-momentum of scientists worldwide to discover and develop new tools that will end the TB epidemic. A few unique features of this conference include sessions that will explore advances across the ecosystem from early discovery through translation and real-world application, as well as sessions that address scientific bottlenecks to be overcome in the search for new tools to prevent, diagnose and definitively cure TB. Finally, the conference will include sessions dedicated to lessons learned from leprosy. There will be numerous opportunities for scientists to catalyze scientific advances that address the global burden of TB.
Program is intended for scientific researchers and clinical audiences.
Join us for this landmark virtual event, brought to you by Keystone Symposia.
Registration for this meeting is now closed.
Abstract Submission
for Short Talk Consideration: Passed
ePoster Abstract Submission: Passed
Financial Aid Application: Passed
#VKSTBepidemic21
David Alland
Rutgers University, New Jersey Medical School, USA
Bruno B. Andrade
Fundação Oswaldo Cruz, Brazil
Clifton E. Barry III
NIAID, National Institutes of Health, USA
Yasmine Belkaid
NIAID, National Institutes of Health, USA
Julio Croda
Ministry of Health, Brazil
Patricia A. Darrah
NIAID, National Institutes of Health, USA
Sarah M. Fortune
Harvard TH Chan School of Public Health, USA
Neel R. Gandhi
Emory University, USA
Lei Gao
Chinese Academy of Medical Sciences, China
Annemieke Geluk
Leiden University Medical Center, Netherlands
Mark Hatherill
University of Cape Town, South Africa
Deborah T. Hung
Broad Institute of MIT and Harvard, USA
Babak Javid
Tsinghua University School of Medicine, China
Shabaana Khader
Washington University School of Medicine, USA
Purvesh Khatri
Stanford University, USA
Cressida Madigan
University of California, San Diego, USA
Guy B. Marks
University of New South Wales, Australia
Katrin D. Mayer-Barber
NIAID, National Institutes of Health, USA
Robert L. Modlin
University of California, Los Angeles, USA
Milton Ozório Moraes
Oswaldo Cruz Institute- Fiocruz, Brazil
Elisa Nemes
University of Cape Town, South Africa
Mihai G. Netea
Radboud University, Netherlands
Olivier Neyrolles
IPBS, CNRS-University of Toulouse, France
Kyu Y. Rhee
Weill Cornell Medical College, USA
Padmini Salgame
Rutgers University, USA
Christopher M. Sassetti
University of Massachusetts Medical School, USA
Alan Sher
NIAID, National Institutes of Health, USA
David R. Sherman
University of Washington, USA
Soumya Swaminathan
World Health Organisation, Switzerland
Gabriel D. Victora
Rockefeller University, USA
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
